This content is machine translated Diabetes Cases Cardio-renal prevention: the revolution in diabetes management in 2020 A 68-year-old patient with type 2 diabetes mellitus is undergoing cardiac rehabilitation after a myocardial infarction. Despite antidiabetic treatment, his HbA1c value is deteriorating and his weight is steadily increasing. However, with the…
View Post 3 min This content is machine translated Diabetic kidney disease Canagliflozin approved in fast track for diabetic nephropathy Kidney protection is extremely important for diabetes sufferers. Recently, canagliflozin became the first SGLT-2 inhibitor in Switzerland to receive a marketing authorization extension to reduce the risk of progression to…
View Post 3 min This content is machine translated Heart failure in type 2 diabetes Indication expansion for SGLT2 inhibitor and combination preparation Because of the high prevalence and mortality, it is particularly important to protect patients with type 2 diabetes from heart failure as early as possible. The indication expansion of dapagliflozin…
View Post 6 min This content is machine translated Type 2 diabetes: SGED Recommendations 2020 Update Cardiovascular risk stratification and personalized therapy. When prescribing antidiabetic therapy, other criteria are relevant today in addition to blood glucose control. The cardiac benefit of SGLT2 inhibitors and GLP1 analogues has been incorporated into international guidelines…
View Post 3 min This content is machine translated Diabetes Cases Management of intolerance to various antidiabetic drugs. A 55-year-old patient, who has had type 2 diabetes mellitus for 15 years, has adverse reactions to a wide variety of antidiabetic drugs that require a change in treatment. In…
View Post 1 min This content is machine translated Diabetes Cases Webcast “Practical Questions on the Current SGED Recommendations 2020” with Prof. Roger Lehmann, M.D. In the webcast, Prof. Lehmann presents the Swiss guidelines for the treatment of type 2 diabetes mellitus , the “most modern and simplest recommendations in the world.” Based on current clinical data,…
View Post 3 min This content is machine translated "A New Era in Diabetes Care" New project to improve diabetes care The recently published expert panel report outlines strategies to optimize treatment for individuals with type 2 diabetes mellitus. Special attention is given to the issue of cardiovascular and renal sequelae.
View Post 5 min This content is machine translated COVID-19 and rheumatism Do not discontinue immunosuppressants! The SARS-CoV-2 pandemic poses special challenges for physicians and patients – even more so if the latter have pre-existing conditions and are on immunosuppressive drugs. Researchers have explored the question…
View Post 5 min This content is machine translated PUBLICITY/ADVERTISEMENT Semaglutide – a GLP-1 analogue from a cardiovascular perspective. GLP-1 analogs are modeled on the natural GLP-1 (glucagon-like peptide 1). In studies, they show potent HbA1C control and weight reduction in patients with type 2 diabetes.1,2,* Their positive effect…
View Post 4 min This content is machine translated Diabetes Cases Cardio-renal protection as an important goal in type 2 diabetes. Cardio-renal protection is one of the most important goals in the management of type 2 diabetes mellitus. Therefore, SGED/SSED recommendations for the treatment of type 2 diabetes mellitus include a…
View Post 4 min This content is machine translated Type 2 diabetes Recommendations for the choice of therapy up to date In recent years, the treatment of type 2 diabetes has been expanded to include more and more options. However, this adds to the complexity of therapy selection. So what can…
